Consequently, upregulating NRF2 by any means would prevent SARS-CoV-2 replication and its associated injuries, and improve COVID-19 patient conditions [22] by resolving COVID-19 associated inflammation and cellular redox and protein homeostasis [19]. The gene discussed is NFE2L2; the disease is COVID-19.